immatics biotechnologies GmbH (IMTXW) — Cash Flow Reinvestment Rate
immatics biotechnologies GmbH (IMTXW) has a Cash Flow Reinvestment Rate of 0.87x as of December 2023, reinvesting $69.03 Million (capex $9.29 Million plus investments $59.74 Million) from operating cash flow of $79.08 Million. Explore IMTXW capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for immatics biotechnologies GmbH across 4 annual periods. Also explore balance sheet size of immatics biotechnologies GmbH for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for immatics biotechnologies GmbH (2018–2023)
Year-by-year capital reinvestment analysis for immatics biotechnologies GmbH. For live market cap and broader valuation context, see IMTXW stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.42x | $62.34 Million | $18.23 Million | $30.96 Million | ▲ +58.5% |
| 2022 | 2.16x | $216.01 Million | $100.13 Million | $6.21 Million | ▲ +1999.2% |
| 2019 | 0.10x | $7.29 Million | $70.97 Million | $2.23 Million | ▼ -84.8% |
| 2018 | 0.68x | $14.02 Million | $20.68 Million | $507.00K | — |